AI model for thyroid cancer diagnosis, with over 90% accuracy and reduced consultation preparation time

An interdisciplinary research team from the LKS Faculty of Medicine of the University of Hong Kong (HKUMed), the InnoHK Laboratory of Data Discovery for Health (InnoHK D24H), and the London

In-utero exposures associated with increased risk of thyroid cancer

A recent study by prof. Tone Bjørge, University of Bergen, and her team shows that thyroid cancer is related to in-utero exposures. Thyroid cancer is diagnosed at a younger age

Pralsetinib achieves tissue-agnostic benefits for patients with RET gene fusions

The highly selective RET inhibitor pralsetinib was well-tolerated and demonstrated robust, durable responses in patients with RET fusion-positive cancers regardless of tumor type, according to results from the international Phase